scholarly article | Q13442814 |
P2093 | author name string | Richard S Jope | |
Tae-Yeon Eom | |||
P2860 | cites work | VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain | Q24303927 |
Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling | Q24322974 | ||
Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis | Q24529125 | ||
A molecular mechanism for the effect of lithium on development | Q24629067 | ||
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
Adult brain neurogenesis and psychiatry: a novel theory of depression | Q28140495 | ||
Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo | Q28577046 | ||
VEGF links hippocampal activity with neurogenesis, learning and memory | Q28578381 | ||
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants | Q28579192 | ||
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants | Q29547516 | ||
Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells | Q29618245 | ||
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus | Q29619400 | ||
The glamour and gloom of glycogen synthase kinase-3 | Q29620533 | ||
Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine | Q30531104 | ||
Anti-bipolar therapy: mechanism of action of lithium | Q33596950 | ||
Serotonin and hippocampal neurogenesis | Q33702854 | ||
Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro. | Q33929938 | ||
Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. | Q34357875 | ||
Neurogenic actions of atypical antipsychotic drugs and therapeutic implications | Q34662630 | ||
Regulation of adult hippocampal neurogenesis - implications for novel theories of major depression | Q34669422 | ||
Trk signaling regulates neural precursor cell proliferation and differentiation during cortical development. | Q34713701 | ||
Opiates inhibit neurogenesis in the adult rat hippocampus | Q35163722 | ||
Neurogenesis in the adult brain: new strategies for central nervous system diseases | Q35639161 | ||
Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions | Q35748119 | ||
In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain | Q36002807 | ||
Adult neurogenesis: from precursors to network and physiology | Q36079007 | ||
Neural precursor cells are protected from apoptosis induced by trophic factor withdrawal or genotoxic stress by inhibitors of glycogen synthase kinase 3. | Q36275171 | ||
Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments | Q36672294 | ||
Neurogenesis and neuroenhancement in the pathophysiology and treatment of bipolar disorder | Q36687844 | ||
Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus | Q36837563 | ||
The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior | Q36925139 | ||
The contribution of failing adult hippocampal neurogenesis to psychiatric disorders | Q37125836 | ||
TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment | Q37127162 | ||
Genetic regulation of behavioral and neuronal responses to fluoxetine | Q38480101 | ||
The effects of clozapine on the GSK-3-mediated signaling pathway | Q40585064 | ||
Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. | Q43972766 | ||
BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents | Q44046056 | ||
Atypical neuroleptics stimulate neurogenesis in adult rat brain | Q44059818 | ||
Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium | Q44264546 | ||
Lithium stimulates progenitor proliferation in cultured brain neurons. | Q44328304 | ||
Lithium inhibits apoptosis of mouse neural progenitor cells | Q44611104 | ||
VEGF is necessary for exercise-induced adult hippocampal neurogenesis | Q44680412 | ||
Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat. | Q44845263 | ||
Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum | Q45287391 | ||
Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats. | Q45310403 | ||
Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex. | Q46012978 | ||
Increased generation of granule cells in adult Bcl-2-overexpressing mice: a role for cell death during continued hippocampal neurogenesis. | Q46785501 | ||
Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis | Q46962136 | ||
Neural precursor cells possess multiple p53-dependent apoptotic pathways | Q46973609 | ||
Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex | Q48120338 | ||
Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor | Q48206434 | ||
Adult treatment with haloperidol increases dentate granule cell proliferation in the gerbil hippocampus | Q48433223 | ||
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. | Q48556742 | ||
Neural stem cell proliferation is decreased in schizophrenia, but not in depression. | Q48686220 | ||
Neurogenesis in the dentate gyrus depends on ciliary neurotrophic factor and signal transducer and activator of transcription 3 signaling | Q48819254 | ||
Electroconvulsive seizure restores neurogenesis and hippocampus-dependent fear memory after disruption by irradiation. | Q50800082 | ||
Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. | Q52012874 | ||
Apoptosis and its relation to the cell cycle in the developing cerebral cortex. | Q52196633 | ||
Neuronal plasticity and survival in mood disorders. | Q52541461 | ||
Increased neurogenesis in a model of electroconvulsive therapy | Q73914669 | ||
Enhancement of hippocampal neurogenesis by lithium | Q74315939 | ||
Neurogenesis in the dentate gyrus of the rat following electroconvulsive shock seizures | Q74332174 | ||
Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication | Q74424004 | ||
Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor | Q80783829 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | phosphorylation | Q242736 |
P304 | page(s) | 494-502 | |
P577 | publication date | 2009-06-11 | |
P1433 | published in | Biological Psychiatry | Q4914961 |
P1476 | title | Blocked inhibitory serine-phosphorylation of glycogen synthase kinase-3alpha/beta impairs in vivo neural precursor cell proliferation | |
P478 | volume | 66 |
Q30485018 | Abnormalities in brain structure and behavior in GSK-3alpha mutant mice |
Q35639737 | Adiponectin stimulates proliferation of adult hippocampal neural stem/progenitor cells through activation of p38 mitogen-activated protein kinase (p38MAPK)/glycogen synthase kinase 3β (GSK-3β)/β-catenin signaling cascade |
Q91947139 | An expanding GSK3 network: implications for aging research |
Q43106553 | Andrographolide Stimulates Neurogenesis in the Adult Hippocampus. |
Q92535110 | Brain 5-HT Deficiency Prevents Antidepressant-Like Effects of High-Fat-Diet and Blocks High-Fat-Diet-Induced GSK3β Phosphorylation in the Hippocampus |
Q39335023 | Caudatin inhibits carcinomic human alveolar basal epithelial cell growth and angiogenesis through modulating GSK3β/β-catenin pathway |
Q30906677 | Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift |
Q42918754 | Clozapine Mobilizes CD34+ Hematopoietic Stem and Progenitor Cells and Increases Plasma Concentration of Interleukin 6 in Patients With Schizophrenia |
Q30495108 | Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances |
Q45023754 | Dual effects of increased glycogen synthase kinase-3β activity on adult neurogenesis |
Q30456006 | Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice |
Q47790879 | Failure to Inactivate Nuclear GSK3β by Ser389-Phosphorylation Leads to Focal Neuronal Death and Prolonged Fear Response |
Q35224304 | Fluoxetine regulates neurogenesis in vitro through modulation of GSK-3β/β-catenin signaling |
Q36105469 | G-protein-coupled receptors in adult neurogenesis |
Q37959957 | GSK-3 Mouse Models to Study Neuronal Apoptosis and Neurodegeneration |
Q37982704 | GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder |
Q30472813 | GSK-3: Functional Insights from Cell Biology and Animal Models |
Q40963450 | GSK3 as a Sensor Determining Cell Fate in the Brain |
Q33543082 | GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism. |
Q48295081 | GSK3β Controls mTOR and Prosurvival Signaling in Neurons |
Q30359195 | GSK3β Overexpression in Dentate Gyrus Neural Precursor Cells Expands the Progenitor Pool and Enhances Memory Skills. |
Q35575758 | GSK3β inhibition promotes synaptogenesis in Drosophila and mammalian neurons |
Q36649760 | GSK3β isoform-selective regulation of depression, memory and hippocampal cell proliferation |
Q38432665 | Gene expression and proliferation biomarkers for antidepressant treatment resistance |
Q37753335 | Glucocorticoids and lithium in adult hippocampal neurogenesis |
Q48256484 | Glycogen Synthase Kinase-3β Regulates Equilibrium Between Neurogenesis and Gliogenesis in Rat Model of Parkinson's Disease: a Crosstalk with Wnt and Notch Signaling |
Q38116597 | Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia |
Q38272835 | Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases |
Q30474415 | Glycogen synthase kinase-3 in the etiology and treatment of mood disorders |
Q38126701 | Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments |
Q30469863 | Hyperactivity, startle reactivity and cell-proliferation deficits are resistant to chronic lithium treatment in adult Nr2e1(frc/frc) mice |
Q35146005 | Impairments in cognition and neural precursor cell proliferation in mice expressing constitutively active glycogen synthase kinase-3. |
Q36640233 | Inflammatory T helper 17 cells promote depression-like behavior in mice |
Q90355848 | Inhibition of GSK-3β on Behavioral Changes and Oxidative Stress in an Animal Model of Mania |
Q37711788 | Intranasal siRNA administration reveals IGF2 deficiency contributes to impaired cognition in Fragile X syndrome mice. |
Q30475816 | Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation? |
Q36767983 | Ketamine exposure during embryogenesis inhibits cellular proliferation in rat fetal cortical neurogenic regions |
Q48039552 | Ketamine up-regulates a cluster of intronic miRNAs within the serotonin receptor 2C gene by inhibiting glycogen synthase kinase-3. |
Q35768941 | Lentiviral silencing of GSK-3β in adult dentate gyrus impairs contextual fear memory and synaptic plasticity |
Q48949563 | Lithium fails to enhance neurogenesis in subventricular zone and dentate subgranular zone after intracerebral hemorrhage in rats |
Q41774912 | Lithium promotes neural precursor cell proliferation: evidence for the involvement of the non-canonical GSK-3β-NF-AT signaling |
Q38122158 | Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication. |
Q38149943 | New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease. |
Q28535092 | Possible role of the glycogen synthase kinase-3 signaling pathway in trimethyltin-induced hippocampal neurodegeneration in mice |
Q38440275 | Proliferation rates and gene expression profiles in human lymphoblastoid cell lines from patients with depression characterized in response to antidepressant drug therapy |
Q28069509 | Recent Advances in Neurogenic Small Molecules as Innovative Treatments for Neurodegenerative Diseases |
Q39891638 | Retroviral induction of GSK-3β expression blocks the stimulatory action of physical exercise on the maturation of newborn neurons. |
Q36851570 | The Role of Neurotrophins in Major Depressive Disorder |
Q54576271 | The apical polarity determinant Crumbs 2 is a novel regulator of ESC-derived neural progenitors. |
Q37972080 | The roles of neurotrophic factor and Wnt signaling in depression |
Q34389210 | Two variants in the fibulin2 gene are associated with lower systolic blood pressure and decreased risk of hypertension |
Q38101982 | Understanding the relationship between GSK-3 and Alzheimer's disease: a focus on how GSK-3 can modulate synaptic plasticity processes |
Q39295832 | Up-regulation of insulin-like growth factor 2 by ketamine requires glycogen synthase kinase-3 inhibition |
Q64117819 | Valproic Acid Stimulates Hippocampal Neurogenesis Activating the Wnt/β-Catenin Signaling Pathway in the APP/PS1/Nestin-GFP Triple Transgenic Mouse Model of Alzheimer's Disease |
Q89459059 | Voltage-gated sodium currents in cerebellar Purkinje neurons: functional and molecular diversity |
Q35001234 | What Are the bona fide GSK3 Substrates? |
Q38117365 | Wnt signaling in the regulation of adult hippocampal neurogenesis |
Search more.